Rehan Raina: Did You Know Your Immune Cells are What Actually Kill Cancer?
Rehan Raina, Quality and Marketing Manager at Salalah Macaroni Co SAOC, shared a post on LinkedIn about recent articles, adding։
“Did you know your immune cells are what actually kill cancer?
As a surgeon who removed hundreds of cancers, this is something I lived firsthand and it took me years to fully reckon with it.
When an oncologist orders a CBC, they are looking at red blood cells for anemia, platelets to prevent bleeding, and neutrophils to avoid infection.
All valid. All important for managing treatment side effects.
But none of those cells kill cancer.
The cells that kill cancer are your natural killer cells and T cells.
They live inside that same CBC under the lymphocyte count.
And for decades, most oncologists never looked at them.
Not out of negligence, but because there was no drug or intervention that could meaningfully increase them.
So the number sat there, ignored.
That is changing now in a significant way.
Researchers have developed a way to extract a patient’s own T cells, engineer them in a lab to recognize and attack cancer cells specifically, and reinfuse them back into the body.
This is called CAR-T cell therapy, and it is already producing outcomes in certain blood cancers that conventional treatment never achieved.
The broader lesson here is one I think about constantly.
Your immune system is your first and most powerful defense against cancer.
The lifestyle choices that protect and strengthen it, sleep, nutrition, stress management, and movement, are not soft wellness advice.
They are oncology.”
Title: Cancer immunotherapy using checkpoint blockade
Authors: Antoni Ribas, Jedd D Wolchok

Title: The future of immune checkpoint therapy
Authors: Padmanee Sharma, James P Allison

Title: NK cells for cancer immunotherapy
Authors: Noriko Shimasaki, Amit Jain, Dario Campana

Title: Treatment of the “syndrome of doubles”
Authors: G N Christodoulou

Proceed to the video attached to the post.
Stay updated on all scientific advances Hemostasis Today.
-
Aug 13, 2026, 18:39Lukas Röthlisberger: Real-World Evidence on Effectiveness and Safety of Rivaroxaban in Children
-
Aug 13, 2026, 18:36Soner Yilmaz: Blood Safety in Türkiye Through More Than 22.5 Million Blood Donations
-
Aug 13, 2026, 18:31Muthukumarasamy Raja: FDA Approval of EZPLAZ Marks a Breakthrough in Emergency Plasma Care
-
Aug 13, 2026, 18:29Peter Zdziarski: Protecting Our Community While Creating a Future Where We Are No Longer Needed
-
Aug 13, 2026, 18:29Morgan E Amos: Thrilled to Receive the Student Research Award From HTRS
-
Aug 13, 2026, 16:38Sheharyar Raza: Plasma Exchange in Multiple Sclerosis
-
Aug 13, 2026, 16:31Juan Manuel Cisneros Carrasco: The True Cost of Blood Donation
-
Aug 13, 2026, 16:25Connie Montgomery: Bridging the Gap Between Patients, Culture and Clinical Trials
-
Aug 13, 2026, 16:16Isabella Presch: A New AI Approach to Protein Engineering